Sir, The recent paper by Morley et al discussed some of the dangers of interpreting the higher Bayley scores at 18 months that were achieved by very low birthweight babies whose mothers expressed an intention to breast feed compared with those whose mothers did not.'
In a detailed analysis of breast feeding and child development in the 1970 National Cohort (CHES), adjusting for all factors predictive of initially deciding to breast feed, strong relationships were found linking breast feeding decision to above average scores in a picture vocabulary test and a human figure drawing test at 5 years of age, and the Edinburgh Reading Test at 10 in both primiparae and multiparae. Furthermore higher average British Ability Scale scores characterised 10 year old children who were breast fed as infants. 2 Language development and vocabulary and drawing skills at 5 years have now been examined for infants with birth weights of less than or more than 2537 g whose mothers breast fed their infant wholly or partially during the first seven days postpartum. In a multiple logistic regression analysis on both birthweight groups, the odds ratio of above average skills in the initially breast fed group were computed, having adjusted for the same factors predictive of breast feeding used by Morley et al: educational qualification of mother, mother's age and parity, marital status, social class, method of delivery, gestational age, birth weight, and sex of infant. No At the time of our report further studies of this use of growth hormone were precluded by the withdrawal of pituitary growth hormone after reports of CreutzfeldtJakob disease. Now that a growth hormone produced by recombinant DNA technology is available, however, the choice of growth hormone over a somatostatin analogue has advantages.
Somatostatin has a very broad range of endocrine activity,' with unwanted effects upon other endocrine axes that do not appear to be produced by growth hormone. Furthermore, on simply practical grounds growth hormone, unlike somatostatin, is available in most regional centres.
In the infant with hyperinsulism, when it is necessary to temporise before surgery, we believe that growth hormone may be preferable, and its use certainly merits further study. 
